BBNX — Beta Bionics, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1674632 ·
Last close
$21.51
Market Cap
$967.73M
52W High
$32.71
52W Low
$8.80
ADV30
1,346,143
Next earnings
2026-10-27
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 32,013,000 | 18,902,000 | -25,578,000 | -23,403,000 | 292,387,000 | 44,318,000 | 36,021,000 |
| Mar 2026 | 27,626,000 | 16,437,000 | -24,271,000 | -21,895,000 | 304,417,000 | 30,206,000 | 33,172,000 |
| Dec 2025 | 32,121,000 | 18,944,000 | -16,124,000 | -13,466,000 | 328,743,000 | 31,576,000 | 41,133,000 |
| Sep 2025 | 27,253,000 | 15,119,000 | -17,043,000 | -14,209,000 | 330,046,000 | 38,485,000 | 35,286,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-55,810,000
Investing CF
$58,916,000
Financing CF
$6,137,000
CapEx
$-5,601,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.65
As of
2026-08-02
Balance + Analyst (yfinance extras)
Retained Earnings
$-415,235,000
Inventory
$23,918,000
Receivables
$20,252,000
ST Investments
$136,171,000
EBIT TTM
$-78,840,000
Pretax Income TTM
$-72,973,000
Interest Exp TTM
—
Analysts
11
Yahoo Snapshot (yfinance, live)
Total Revenue
$119,013,000
EBITDA
$-80,799,000
Free Cash Flow
$-40,294,000
Enterprise Value
$571,502,144
Total Cash
$180,488,992
Total Debt
$6,512,000
Shares Out
44,989,688
Trailing EPS
$-1.60
Book Value
$5.70
ROE
-26.2%
ROA
-16.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 100,251,000 | -71,681,000 | -73,200,000 | 328,743,000 | 41,133,000 | 287,610,000 | -50,925,000 |
| Dec 2024 | 65,124,000 | -45,251,000 | -54,756,000 | 149,645,000 | 395,005,000 | -245,360,000 | -48,273,000 |
| Dec 2023 | 11,995,000 | -35,850,000 | -44,099,000 | 110,040,000 | 313,145,000 | -203,105,000 | -32,445,000 |
| Dec 2022 | 179,000 | -65,844,000 | -64,751,000 | 35,527,000 | 205,561,000 | -170,034,000 | -60,208,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-2.31
Max Pain — expiry 2026-10-16 (volume-derived — Yahoo OI feed degraded)
max pain strike: $12.50 · spot: $20.06 · call volume: 121 · put volume: 1
Expected Move to 2026-10-16:
±$3.40
(16.95%) —
implied range
$16.66 –
$23.46
· ATM straddle on $20.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PRCT | PROCEPT BioRobotics Corp | $979.00M | $17.20 | — |
| BVS | Bioventus Inc. | $943.29M | $13.81 | — |
| CBLL | Ceribell, Inc. | $909.18M | $23.69 | — |
| SGP | SpyGlass Pharma, Inc. | $905.44M | $27.07 | — |
| STVN | Stevanato Group S.p.A. | $1.05B | $21.13 | — |
News headlines (Yahoo Finance, 1h cache)
Beta Bionics Announces Agreement Integrate the iLet® Bionic Pancreas and mint™ with Senseonics’ Eversense® 365
2026-09-22 11:30 · Yahoo
Beta Bionics Announces Closing of $172.5 Million Public Offering of Common Stock
2026-09-17 20:05 · Yahoo
Beta Bionics, Inc. (BBNX) Surges 15.3%: Is This an Indication of Further Gains?
2026-09-17 10:21 · Yahoo
Beta Bionics (BBNX) Stock Sees Fair Value Lift As Analysts Reassess Pipeline Timing
2026-09-16 06:12 · Yahoo
Beta Bionics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
2026-09-16 03:56 · Yahoo
Beta Bionics’ insulin patch pump gets FDA nod
2026-09-14 15:22 · Yahoo
Beta Bionics Announces FDA Clearance of Mint™, the Company’s Transformative Patch Pump, and Unveils 3D Intelligence™ as its Next-Generation Insulin Dosing Algorithm
2026-09-14 11:30 · Yahoo
Beta Bionics (BBNX) Q2 2026 Earnings Call Transcript
2026-08-08 01:14 · Yahoo
Beta Bionics (BBNX) Stock Fair Value Falls As Medtech Reset Tempers iLet And Mint Optimism
2026-07-25 20:06 · Yahoo
Beta Bionics to Announce Second Quarter 2026 Financial Results on July 29, 2026
2026-07-01 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.